Contribution: Innovation for Defence Excellence and Security Program - Innovation Netowrks
MJMG Holdings Inc.
$1,331,809.00
SARS-CoV-2 Point of Care Test Development
FY 2020-21 · 2020-06-18
Summary
This project is to develop and qualify a rapid Point-of-Care diagnostic test for the SARS-CoV-2 virus that causes Covid-19. The test will be run on a portable reader that will be capable of operating in a clinic or in the field using a battery power source.
Department
Program
Innovation for Defence Excellence and Security Program - Innovation Netowrks
Recipient
Location
Toronto|Toronto, Ontario, Canada
Recipient Type
For-profit organization
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
As published
Agreement End Date
2021-09-30
Agreement Start Date
2020-06-18
Agreement Title
SARS-CoV-2 Point of Care Test Development
Agreement Type
Contribution
Agreement Value
$1,331,809.00
Amendment Date
2021-06-30
Amendment Number
2
Description
This project is to develop and qualify a rapid Point-of-Care diagnostic test for the SARS-CoV-2 virus that causes Covid-19. The test will be run on a portable reader that will be capable of operating in a clinic or in the field using a battery power source.
Description (French)
Ce projet vise à développer et à qualifier un test de diagnostic rapide au point de service pour le virus SARS-CoV-2 qui cause le Covid-19. Le test sera effectué sur un lecteur portable qui fonctionnera dans une clinique ou sur le terrain à l'aide d'une batterie.
Organization Code
dnd-mdn
Organization
National Defence | Défense nationale
Program Name
Innovation for Defence Excellence and Security Program - Innovation Netowrks
Program Name (French)
Programme d’innovation pour la défense, l’excellence et la sécurité - Réseaux d'innovation
Program Purpose
Collaborate with academic and private sector partners to build a network of expertise to support Canada’s current and future defence and security needs.
Program Purpose (French)
Collaborez avec des partenaires des secteurs universitaire et industriel afin de mettre en place un réseau d’expertise pour soutenir les besoins actuels et futurs du Canada en matière de défense et de sécurité.
Recipient City
Toronto|Toronto
Recipient Country
CA
Recipient Legal Name
MJMG Holdings Inc.
Recipient Operating Name
Custom Biologics
Recipient Postal Code
M9W 4Z4
Recipient Province or Territory
ON
Recipient Type
O
Reference Number
180-2021-2022-Q1-R&D-001
